Ausgabe 2/2005
Inhalt (22 Artikel)
The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers
Amanda B Spurdle, Antonis C Antoniou, David L Duffy, Nirmala Pandeya, Livia Kelemen, Xiaoqing Chen, Susan Peock, Margaret R Cook, Paula L Smith, David M Purdie, Beth Newman, Gillian S Dite, Carmel Apicella, Melissa C Southey, Graham G Giles, John L Hopper, Georgia Chenevix-Trench, Douglas F Easton
Haplotype analysis of common variants in the BRCA1 gene and risk of sporadic breast cancer
David G Cox, Peter Kraft, Susan E Hankinson, David J Hunter
Breast implants following mastectomy in women with early-stage breast cancer: prevalence and impact on survival
Gem M Le, Cynthia D O'Malley, Sally L Glaser, Charles F Lynch, Janet L Stanford, Theresa HM Keegan, Dee W West
Knockdown of c-Myc expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo
Yi-hua Wang, Shuang Liu, Guo Zhang, Cui-qi Zhou, Hong-xia Zhu, Xiao-bo Zhou, Lan-ping Quan, Jin-feng Bai, Ning-zhi Xu
SULT1A1 genotype, active and passive smoking, and breast cancer risk by age 50 years in a German case–control study
Carmen Lilla, Angela Risch, Silke Kropp, Jenny Chang-Claude
High expression of focal adhesion kinase (p125FAK) in node-negative breast cancer is related to overexpression of HER-2/neu and activated Akt kinase but does not predict outcome
Klaus Jürgen Schmitz, Florian Grabellus, Rainer Callies, Friedrich Otterbach, Jeremias Wohlschlaeger, Bodo Levkau, Rainer Kimmig, Kurt Werner Schmid, Hideo Andreas Baba
Downregulation of the anaphase-promoting complex (APC)7 in invasive ductal carcinomas of the breast and its clinicopathologic relationships
Kwang-Hwa Park, Sung-E Choi, Minseob Eom, Yup Kang
Relative microvessel area of the primary tumour, and not lymph node status, predicts the presence of bone marrow micrometastases detected by reverse transcriptase polymerase chain reaction in patients with clinically non-metastatic breast cancer
Ina H Benoy, Roberto Salgado, Hilde Elst, Peter Van Dam, Joost Weyler, Eric Van Marck, Simon Scharpé, Peter B Vermeulen, Luc Y Dirix
Common ERBB2 polymorphisms and risk of breast cancer in a white British population: a case–control study
Patrick R Benusiglio, Fabienne Lesueur, Craig Luccarini, Donald M Conroy, Mitul Shah, Douglas F Easton, Nick E Day, Alison M Dunning, Paul D Pharoah, Bruce AJ Ponder
Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study
Anna-Mária Tőkés, Janina Kulka, Sándor Paku, Ágnes Szik, Csilla Páska, Pál Kaposi Novák, László Szilák, András Kiss, Krisztina Bögi, Zsuzsa Schaff
The challenge of measuring circulating estradiol at low concentrations
Paolo Toniolo, Annekatrin Lukanova
Claudin 7 expression and localization in the normal murine mammary gland and murine mammary tumors
Brigitte Blackman, Tanya Russell, Steven K Nordeen, Daniel Medina, Margaret C Neville
Long-term prognostic significance of HER-2/neu in untreated node-negative breast cancer depends on the method of testing
Marcus Schmidt, Barbara Lewark, Nikolai Kohlschmidt, Christiane Glawatz, Erik Steiner, Berno Tanner, Henryk Pilch, Wolfgang Weikel, Heinz Kölbl, Hans-Anton Lehr
Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situhybridization and immunohistochemistry
Marta Salido, Ignasi Tusquets, Josep M Corominas, Marta Suarez, Blanca Espinet, Cristina Corzo, Meritxell Bellet, Xavier Fabregat, Sergi Serrano, Francesc Solé
Endocrinology and hormone therapy in breast cancer: Endocrine therapy in premenopausal women
Kathleen Pritchard
Do breast implants after a mastectomy affect subsequent prognosis and survival?
Louise A Brinton